TY - JOUR
T1 - Uncovering a novel role of PLCβ4 in selectively mediating TCR signaling in CD8+ but not CD4+ T cells
AU - Sasai, Miwa
AU - Ma, Ji Su
AU - Okamoto, Masaaki
AU - Nishino, Kohei
AU - Nagaoka, Hikaru
AU - Takashima, Eizo
AU - Pradipta, Ariel
AU - Lee, Youngae
AU - Kosako, Hidetaka
AU - Suh, Pann Ghill
AU - Yamamoto, Masahiro
N1 - Funding Information:
We thank Drs. A. Iwasaki (Yale University) and S. Yamamoto (Medical College of Oita) for helpful discussion. We thank M. Enomoto (Osaka University) for secretarial assistance. This study was supported by the Japan Agency for Medical Research and Development: Research Program on Emerging and Re-emerging Infectious Diseases (JP20fk0108137 for M. Yamamoto), Japanese Initiative for Progress of Research on Infectious Diseases for Global Epidemic (JP20wm0325010 for M. Yamamoto), and Strategic International Collaborative Research Program (JP19jm0210067 for M. Yamamoto); the Ministry of Education, Culture, Sports, Science and Technology: Grant-in-Aid for Transformative Research Area (B) (20H05771 for M. Yamamoto), for Scientific Research on Innovative Areas (19H04809 for M. Yamamoto), for Scientific Research (B) (18KK0226 for M. Yamamoto and 18H02642 for M. Sasai), and for Scientific Research (A) (19H00970 for M. Yamamoto); Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences, Tokushima University for M. Yamamoto; Takeda Science Foundation for M. Yamamoto and M. Sasai; Mochida Memorial Foundation for Medical and Pharmaceutical Research for M. Yamamoto and M. Sasai; Uehara Memorial Foundation for M. Yamamoto and M. Sasai; Naito Foundation for M. Yamamoto and M. Sasai; Astellas Foundation for Research on Metabolic Disorders for M. Sasai; and Research Foundation for Microbial Diseases of Osaka University for M. Yamamoto. Author contributions: M. Sasai, J.S. Ma, M. Okamoto, K. Nishino, H. Nagaoka, E. Takashima, H. Kosako, and M. Yamamoto designed and performed experiments, analyzed the data, and prepared the figures; A. Pradipta, Y. Lee, and P.-G. Suh prepared research reagents and mice; M. Yamamoto conceived the project and supervised this research.
Funding Information:
This study was supported by the Japan Agency for Medical Research and Development: Research Program on Emerging and Re-emerging Infectious Diseases (JP20fk0108137 for M. Yamamoto), Japanese Initiative for Progress of Research on Infectious Diseases for Global Epidemic (JP20wm0325010 for M. Yamamoto), and Strategic International Collaborative Research Program (JP19jm0210067 for M. Yamamoto); the Ministry of Education, Culture, Sports, Science and Technology: Grant-in-Aid for Transformative Research Area (B) (20H05771 for M. Yamamoto), for Scientific Research on Innovative Areas (19H04809 for M. Yamamoto), for Scientific Research (B) (18KK0226 for M. Yamamoto and 18H02642 for M. Sasai), and for Scientific Research (A) (19H00970 for M. Yamamoto); Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences, Tokushima University for M. Yamamoto; Takeda Science Foundation for M. Yamamoto and M. Sasai; Mochida Memorial Foundation for Medical and Pharmaceutical Research for M. Yamamoto and M. Sasai; Uehara Memorial Foundation for M. Yamamoto and M. Sasai; Naito Foundation for M. Yamamoto and M. Sasai; Astellas Foundation for Research on Metabolic Disorders for M. Sasai; and Research Foundation for Microbial Diseases of Osaka University for M. Yamamoto.
Publisher Copyright:
© 2021 Sasai et al.
PY - 2021/5/10
Y1 - 2021/5/10
N2 - Because of their common signaling molecules, the main T cell receptor (TCR) signaling cascades in CD4+ and CD8+ T cells are considered qualitatively identical. Herein, we show that TCR signaling in CD8+ T cells is qualitatively different from that in CD4+ T cells, since CD8α ignites another cardinal signaling cascade involving phospholipase C β4 (PLCβ4). TCR-mediated responses were severely impaired in PLCβ4-deficient CD8+ T cells, whereas those in CD4+ T cells were intact. PLCβ4-deficient CD8+ T cells showed perturbed activation of peripheral TCR signaling pathways downstream of IP3 generation. Binding of PLCβ4 to the cytoplasmic tail of CD8α was important for CD8+ T cell activation. Furthermore, GNAQ interacted with PLCβ4, mediated double phosphorylation on threonine 886 and serine 890 positions of PLCβ4, and activated CD8+ T cells in a PLCβ4-dependent fashion. PLCβ4-deficient mice exhibited defective antiparasitic host defense and antitumor immune responses. Altogether, PLCβ4 differentiates TCR signaling in CD4+ and CD8+ T cells and selectively promotes CD8+ T cell-dependent adaptive immunity.
AB - Because of their common signaling molecules, the main T cell receptor (TCR) signaling cascades in CD4+ and CD8+ T cells are considered qualitatively identical. Herein, we show that TCR signaling in CD8+ T cells is qualitatively different from that in CD4+ T cells, since CD8α ignites another cardinal signaling cascade involving phospholipase C β4 (PLCβ4). TCR-mediated responses were severely impaired in PLCβ4-deficient CD8+ T cells, whereas those in CD4+ T cells were intact. PLCβ4-deficient CD8+ T cells showed perturbed activation of peripheral TCR signaling pathways downstream of IP3 generation. Binding of PLCβ4 to the cytoplasmic tail of CD8α was important for CD8+ T cell activation. Furthermore, GNAQ interacted with PLCβ4, mediated double phosphorylation on threonine 886 and serine 890 positions of PLCβ4, and activated CD8+ T cells in a PLCβ4-dependent fashion. PLCβ4-deficient mice exhibited defective antiparasitic host defense and antitumor immune responses. Altogether, PLCβ4 differentiates TCR signaling in CD4+ and CD8+ T cells and selectively promotes CD8+ T cell-dependent adaptive immunity.
UR - http://www.scopus.com/inward/record.url?scp=85105723438&partnerID=8YFLogxK
U2 - 10.1084/jem.20201763
DO - 10.1084/jem.20201763
M3 - Article
C2 - 33970189
AN - SCOPUS:85105723438
SN - 0022-1007
VL - 218
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 7
M1 - e20201763
ER -